Bibliographic Details
| Title: |
A Total of 207 Days of Veno-Venous Extracorporeal Membrane Oxygenation Support for Severe COVID-19 Prior to Successful Lung Transplantation: A Case Report. |
| Authors: |
Naar, Jan1 (AUTHOR) jan.naar@seznam.cz, Kruger, Andreas1 (AUTHOR), Vondrakova, Dagmar1 (AUTHOR), Janotka, Marek1 (AUTHOR), Kubele, Jan2 (AUTHOR), Lischke, Robert3 (AUTHOR), Kolarova, Milena4 (AUTHOR), Neuzil, Petr1 (AUTHOR), Ostadal, Petr1 (AUTHOR) |
| Source: |
Journal of Personalized Medicine. Dec2022, Vol. 12 Issue 12, p2028. 8p. |
| Subject Terms: |
*LUNGS, *EXTRACORPOREAL membrane oxygenation, *LUNG transplantation, *RIGHT ventricular dysfunction, *COVID-19, *PULMONARY hypertension, *NEUROENDOCRINE cells |
| Abstract: |
Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a life-saving treatment for respiratory failure that may serve as a bridge to patient recovery or lung transplantation. In COVID-19, recovery is somewhat unpredictable and occasionally occurs after >100 days on VV-ECMO support. Thus, determining therapy cessation may be difficult. We report the case of a 59-year-old male without specific risk factors admitted to a tertiary center for rapidly progressive respiratory failure due to severe COVID-19, despite aggressive mechanical ventilatory support. Immediate insertion of VV-ECMO was associated with prompt resolution of hypoxemia and hypercapnia; however, all therapeutic efforts to wean the patient from VV-ECMO failed. During the prolonged hospitalization on VV-ECMO, sepsis was the most life-threatening complication. The patient overcame roughly 40 superinfections, predominantly affecting the respiratory tract, and spent 183 days on antimicrobial treatment. Although the function of other organ systems was generally stable, gradually progressive right ventricular dysfunction due to precapillary pulmonary hypertension required increasing doses of inotropes. A successful lung transplantation was performed after 207 days of VV-ECMO support. The present case provides evidence for prolonged VV-ECMO therapy as a bridge to lung transplantation in severe COVID-19 despite numerous, predominantly infectious complications. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Personalized Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
